Tachycardia
Critical Alerts
- Unstable tachycardia (hypotension, altered consciousness, ischemia, acute heart failure) requires immediate cardioversion
- Wide complex tachycardia should be treated as VT until proven otherwise
- Avoid AV nodal blockers in atrial fibrillation with WPW (can cause VF)
- Polymorphic VT (Torsades de Pointes) requires IV magnesium, not amiodarone
- Regular narrow complex tachycardia often responds to vagal maneuvers or adenosine
Key Diagnostics
- 12-lead ECG (essential for classification)
- Continuous cardiac monitoring
- Electrolytes (K+, Mg2+, Ca2+)
- Troponin if ischemia suspected
- TSH for new-onset atrial fibrillation
- Medication/toxicology screen if indicated
Emergency Treatments
- Unstable: Synchronized cardioversion (50-200J biphasic)
- Stable narrow regular: Vagal maneuvers → Adenosine 6mg → 12mg → 12mg
- Stable narrow irregular (AF): Rate control (diltiazem, metoprolol)
- Stable wide regular (VT): Amiodarone 150mg IV over 10 min
- Torsades de Pointes: Magnesium 2g IV bolus, defibrillation if unstable
Tachycardia is defined as a heart rate greater than 100 beats per minute in adults. While sinus tachycardia is a physiologic response to various stimuli, pathological tachycardias arise from abnormal impulse generation or conduction and may be life-threatening.
Classification by Mechanism
Automaticity
- Enhanced normal automaticity (sinus tachycardia)
- Abnormal automaticity (ectopic atrial tachycardia)
Triggered Activity
- Early afterdepolarizations (Torsades de Pointes)
- Delayed afterdepolarizations (digitalis toxicity)
Re-entry
- Macro-re-entry (atrial flutter, AVRT)
- Micro-re-entry (AVNRT, VT)
Classification by QRS Width and Regularity
| QRS Width | Regular | Irregular |
|---|---|---|
| Narrow (<120ms) | Sinus tach, SVT, atrial flutter | AF, MAT, flutter with variable block |
| Wide (≥120ms) | VT, SVT with aberrancy, paced rhythm | AF with aberrancy, polymorphic VT, AF with WPW |
Electrical Conduction System
Normal Conduction
- SA node → Atria
- AV node (delay)
- Bundle of His → Bundle branches
- Purkinje fibers → Ventricles
Re-entrant Mechanisms
Requirements for Re-entry
- Two functionally distinct pathways
- Unidirectional block in one pathway
- Slow conduction in alternate pathway
- Recovery of excitability in blocked pathway
Common Re-entrant Circuits
| Arrhythmia | Circuit |
|---|---|
| AVNRT | Dual AV node pathways (slow/fast) |
| AVRT | Accessory pathway (e.g., WPW) |
| Atrial flutter | Right atrial macroreentrant |
| VT | Scar-related ventricular circuit |
Wolff-Parkinson-White (WPW) Syndrome
Accessory Pathway Conduction
- Bypass tract connects atria and ventricles
- Delta wave on ECG (during sinus rhythm)
- Orthodromic AVRT: Narrow complex (antegrade via AV node)
- Antidromic AVRT: Wide complex (antegrade via accessory pathway)
Danger in AF with WPW
- AV node blockers can promote accessory pathway conduction
- Very rapid ventricular response
- Can degenerate to VF
Torsades de Pointes
Mechanism
- Triggered by early afterdepolarizations
- Usually in setting of prolonged QT interval
- Causes: QT-prolonging drugs, hypokalemia, hypomagnesemia, bradycardia
Symptoms
Common Symptoms
| Symptom | Frequency | Notes |
|---|---|---|
| Palpitations | Very common | Awareness of rapid/irregular heartbeat |
| Dyspnea | Common | Reduced cardiac output |
| Chest pain | Common | May indicate ischemia |
| Dizziness | Common | Cerebral hypoperfusion |
| Syncope/near-syncope | Less common | Indicates hemodynamic compromise |
| Polyuria | Classic for SVT | ANP release from atrial stretch |
Symptoms Suggesting Instability
Physical Examination
Vital Signs
Cardiac Examination
| Finding | Significance |
|---|---|
| Regular vs irregular rhythm | Classification |
| Cannon A waves in neck | AV dissociation (VT) |
| Variable S1 intensity | AV dissociation |
| New murmur | May indicate structural disease |
| S3/S4 gallop | Heart failure |
Signs of Instability
ECG Characteristics by Arrhythmia
Narrow Complex Tachycardias
| Arrhythmia | Rate | Regularity | P Waves | Key Features |
|---|---|---|---|---|
| Sinus tachycardia | 100-150 | Regular | Upright in II | Gradual onset/offset |
| AVNRT | 150-250 | Regular | Hidden or pseudo r' (V1), pseudo S (II,III,aVF) | Abrupt onset/offset |
| AVRT | 150-250 | Regular | Visible after QRS (RP <PR) | May see delta wave in sinus |
| Atrial flutter | 150 (~300/2) | Regular | Sawtooth (II, III, aVF) | 2:1 block common |
| Atrial fibrillation | Varies | Irregularly irregular | Absent | Fibrillatory baseline |
| MAT | Varies | Irregularly irregular | ≥3 P wave morphologies | COPD, hypoxia |
| Ectopic atrial tach | 100-250 | Regular | Abnormal morphology | Often automatic |
Wide Complex Tachycardias
| Feature | Favors VT | Favors SVT with Aberrancy |
|---|---|---|
| AV dissociation | Strong for VT | - |
| Capture/fusion beats | Diagnostic for VT | - |
| Very wide QRS (>60ms) | VT | - |
| Positive/negative concordance (precordial) | VT | - |
| Known prior MI or structural heart disease | VT | - |
| Prior BBB with same morphology | - | SVT with known BBB |
| Age >0 | More likely VT | - |
Brugada Criteria for VT
- Absence of RS in precordial leads → VT
- RS interval >100ms in any precordial lead → VT
- AV dissociation → VT
- Morphology criteria in V1/V2 and V6 → VT
Signs of Hemodynamic Instability
| Red Flag | Concern | Action |
|---|---|---|
| SBP <90 mmHg | Hypotension | Immediate cardioversion |
| Altered mental status | Cerebral hypoperfusion | Cardioversion |
| Chest pain with ischemic ECG changes | Ongoing ischemia | Cardioversion |
| Acute pulmonary edema | Heart failure | Cardioversion |
| Signs of shock | Hypoperfusion | Cardioversion |
High-Risk Arrhythmias
| Arrhythmia | Risk | Immediate Action |
|---|---|---|
| Polymorphic VT/Torsades | Degeneration to VF | Magnesium, defibrillation |
| Wide complex tachycardia with hemodynamic compromise | VT | Cardioversion |
| Very rapid AF (>00 bpm) | May indicate WPW | Avoid AV nodal blockers |
| Irregular wide complex tachycardia | AF with WPW | Procainamide or cardioversion |
| Monomorphic VT | Sudden death risk | Antiarrhythmics, cardioversion |
Approach to Narrow Complex Tachycardia
Step 1: Regular or Irregular?
Regular NCT
- Sinus tachycardia
- AVNRT
- AVRT (orthodromic)
- Atrial flutter with fixed block
- Ectopic atrial tachycardia
Irregular NCT
- Atrial fibrillation
- Atrial flutter with variable block
- Multifocal atrial tachycardia
- Sinus tachycardia with ectopy
Approach to Wide Complex Tachycardia
Assume VT until proven otherwise (75-80% of WCT is VT)
Differential
- Ventricular tachycardia (most common)
- SVT with aberrant conduction (LBBB, RBBB)
- SVT with pre-excitation (antidromic AVRT)
- Pacemaker-mediated tachycardia
- Hyperkalemia with sinus tachycardia
Secondary Causes of Sinus Tachycardia
| Category | Examples |
|---|---|
| Physiological | Exercise, anxiety, pain |
| Hypovolemia | Dehydration, hemorrhage |
| Anemia | Blood loss, hemolysis |
| Infection | Sepsis, fever |
| Metabolic | Hyperthyroidism, hypoglycemia |
| Cardiac | Heart failure, MI, PE, tamponade |
| Toxicological | Stimulants, anticholinergics, withdrawal |
| Medications | Beta-agonists, caffeine, theophylline |
Initial Assessment
ABCDE Approach
- Airway: Patent
- Breathing: Assess for pulmonary edema
- Circulation: Pulse quality, BP, perfusion
- Disability: Mental status
- Exposure: Signs of underlying cause
Key Questions
- Stable or unstable?
- Narrow or wide QRS?
- Regular or irregular?
ECG Interpretation Algorithm
Tachycardia (>100 bpm)
↓
QRS <120ms (Narrow) or ≥120ms (Wide)?
↓
[NARROW] [WIDE]
↓ ↓
Regular or Irregular? Treat as VT until proven
↓ ↓
[Regular] [Irregular] Cardiovert if unstable
↓ ↓ OR
Vagal → AF MAT Antiarrhythmics if stable
Adenosine Flutter w/
variable block
Laboratory Studies
| Test | Purpose |
|---|---|
| 12-lead ECG | Arrhythmia classification |
| BMP | K+, Mg2+, Ca2+, renal function |
| CBC | Anemia, infection |
| Troponin | Ischemia, demand ischemia |
| TSH | Hyperthyroidism (new AF) |
| D-dimer | PE (if suspected) |
| Drug levels | Digoxin, theophylline |
| Toxicology | If stimulant/poisoning suspected |
Imaging
- Chest X-ray: Cardiomegaly, pulmonary edema
- Echocardiography: Structural heart disease, EF, wall motion abnormalities
- CT-PA: If PE suspected
Unstable Tachycardia Algorithm
Patient Unstable (hypotension, AMS, ischemia, acute HF)?
↓
[YES] → SYNCHRONIZED CARDIOVERSION
↓
Narrow Regular: 50-100J
Narrow Irregular (AF): 120-200J biphasic
Wide Regular: 100J (may need 200J)
Wide Irregular (polymorphic VT): DEFIBRILLATION (unsync) 120-200J
↓
Consider sedation if patient conscious (etomidate, midazolam)
Repeat at higher energy if needed
Stable Narrow Complex Regular Tachycardia
Step 1: Vagal Maneuvers
- Valsalva maneuver (modified Valsalva more effective)
- Carotid sinus massage (if no contraindications)
- Ice water immersion (diving reflex)
Modified Valsalva Technique
- Patient blows into syringe for 15 seconds (generate 40mmHg)
- Immediately lay patient supine
- Raise legs to 45° for 15 seconds
- Return to semi-recumbent position
Step 2: Adenosine
First dose: 6mg rapid IV push (central preferred)
Follow immediately with 20mL NS flush
Wait: 1-2 minutes
↓
Second dose: 12mg if no conversion
↓
Third dose: 12mg if still no conversion
Adenosine Notes
- Very short half-life (~10 seconds)
- Causes brief asystole/bradycardia (warn patient)
- May cause flushing, chest tightness (reassure)
- Use 3mg initially if central line or on dipyridamole
- May need higher dose if on caffeine/theophylline
Step 3: If Adenosine Fails
| Drug | Dose | Notes |
|---|---|---|
| Diltiazem | 15-20mg IV over 2 min | May repeat 20-25mg |
| Verapamil | 2.5-5mg IV over 2 min | May repeat 5-10mg |
| Metoprolol | 5mg IV, repeat q5min x3 | Caution in heart failure |
Stable Narrow Complex Irregular Tachycardia (AF/Flutter)
Rate Control
| Drug | Dose | Notes |
|---|---|---|
| Diltiazem | 15-20mg IV, then 5-15mg/hr | First-line in most |
| Metoprolol | 5mg IV q5min x3 | Avoid in asthma, CHF |
| Digoxin | 0.5mg IV, then 0.25mg q6h x2 | Slow onset, HF ok |
| Amiodarone | 150mg IV over 10 min | AF with HF/hypotension |
Rhythm Control Considerations
- <48 hours duration: May cardiovert without anticoagulation
- >48 hours or unknown: TEE-guided cardioversion or anticoagulation x3 weeks then cardiovert
- Pharmacological: Ibutilide, flecainide, propafenone, amiodarone
Wide Complex Tachycardia - Stable
Assume VT - Treat with:
Amiodarone: 150mg IV over 10 minutes
May repeat 150mg in 10-15 min if needed
Then 1mg/min infusion x6 hours, then 0.5mg/min x18 hours
OR
Procainamide: 20-50mg/min until:
- Arrhythmia terminates
- Hypotension
- QRS widens >50%
- Total dose 17mg/kg
Then 1-4mg/min maintenance
OR
Lidocaine: 1-1.5mg/kg IV bolus
0.5-0.75mg/kg q5-10min (max 3mg/kg)
Then 1-4mg/min infusion
Torsades de Pointes
Step 1: Magnesium sulfate 2g IV bolus over 1-2 min
Follow with 1-2g/hr infusion
Step 2: If not converting/unstable: DEFIBRILLATION (not sync)
Step 3: Increase heart rate (shortens QT)
- Isoproterenol infusion
- Temporary overdrive pacing (100-120 bpm)
Step 4: Correct underlying cause
- Stop QT-prolonging drugs
- Correct K+ to 4.5-5 mEq/L
- Correct Mg2+ to 2+ mEq/L
DO NOT USE: Amiodarone, sotalol, procainamide (prolong QT)
Atrial Fibrillation with WPW
Signs of Pre-excitation in AF
- Very rapid rate (often >200 bpm)
- Irregular wide complex
- Varying QRS width (fusion beats)
Treatment
- DO NOT USE: Adenosine, digoxin, CCBs, beta-blockers
- USE: Procainamide or electrical cardioversion
- If unstable: Immediate cardioversion
Admission Criteria
ICU/Telemetry
- Hemodynamic instability
- Cardioversion performed
- VT or high-risk arrhythmia
- Significant structural heart disease
- Ongoing ischemia
- New heart failure
Observation/Telemetry
- First episode requiring treatment
- Symptomatic recurrence after treatment
- Need for medication adjustment
- Electrolyte abnormalities
Discharge Criteria
- Stable rhythm (sinus or controlled AF)
- Hemodynamically stable
- No concerning symptoms
- Electrolytes normal
- Clear diagnosis with management plan
- Follow-up arranged
Outpatient Referrals
| Referral | Indication |
|---|---|
| Cardiology | All first-time arrhythmias needing treatment |
| Electrophysiology | Recurrent SVT, WPW, VT for ablation |
| Emergency department return | Recurrent symptoms |
Understanding Tachycardia
- Tachycardia means fast heart rate
- Many causes exist, from benign to serious
- Treatment depends on the type and cause
- Some conditions can be cured with ablation procedures
Vagal Maneuvers at Home
For patients with documented SVT:
- Valsalva maneuver (bearing down)
- Cold water on face
- Only attempt if trained and safe to do so
Warning Signs to Return
- Palpitations lasting >15-20 minutes
- Associated chest pain
- Shortness of breath
- Dizziness or near-fainting
- Fainting
- Palpitations with exercise
Medication Adherence
- Take rate control medications as prescribed
- Do not miss anticoagulation doses if prescribed
- Avoid excessive caffeine and alcohol
- Report side effects promptly
Pediatric Considerations
Normal Heart Rates by Age
| Age | Normal HR | Tachycardia Threshold |
|---|---|---|
| Infant | 100-160 | >80-190 |
| 1-3 years | 90-150 | >50 |
| 3-5 years | 80-140 | >40 |
| >0 years | Similar to adult | >00 |
SVT in Children
- Most common arrhythmia in pediatrics
- Often AVRT (accessory pathway)
- Vagal maneuvers: Ice to face very effective
- Adenosine dosing: 0.1mg/kg (max 6mg) then 0.2mg/kg (max 12mg)
Elderly Patients
- Higher risk of falls with hypotension
- More likely to have structural heart disease
- More sensitive to medications
- Caution with rate control agents
Pregnancy
Safe Medications
- Adenosine: Safe
- Beta-blockers: Generally safe (prefer metoprolol, labetalol)
- Cardioversion: Safe at any gestational age
Avoid if Possible
- Amiodarone (thyroid, neurological effects on fetus)
- ACE inhibitors (if treating underlying cause)
Heart Failure
- Avoid negative inotropes when possible
- Amiodarone preferred for rate control
- Digoxin remains option
- Cardioversion may improve hemodynamics rapidly
Performance Indicators
| Metric | Target |
|---|---|
| 12-lead ECG within 10 min | >5% |
| Time to cardioversion (unstable) | <10 min |
| Documentation of QRS width | 100% |
| Electrolytes checked | 100% |
| Anticoagulation assessment for AF | 100% |
| Follow-up arranged | 100% |
Documentation Requirements
- 12-lead ECG findings
- Classification of tachycardia
- Hemodynamic status
- Treatments given and response
- Post-treatment rhythm
- Anticoagulation plan (if AF)
- Disposition rationale
- Follow-up instructions
Diagnostic Pearls
- Wide complex = VT until proven otherwise (80% are VT)
- Look for AV dissociation - cannon A waves, variable S1
- Regular at 150 bpm - think atrial flutter with 2:1 block
- Irregularly irregular without P waves = Atrial fibrillation
- Adenosine can be diagnostic even if it doesn't convert
Treatment Pearls
- Unstable = cardiovert - don't waste time with drugs
- Modified Valsalva has higher success than standard
- Adenosine needs fast push - arm with tourniquet, stopcock setup
- Avoid AV blockers in WPW with AF - can cause VF
- Magnesium is first-line for Torsades - not amiodarone
Disposition Pearls
- First VT = admission even if terminated
- Recurrent SVT may benefit from ablation - refer to EP
- New AF needs stroke risk assessment (CHA2DS2-VASc)
- Ensure electrolytes normalized before discharge
- Follow-up with cardiology for all arrhythmias requiring treatment
- January CT, et al. 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. Circulation. 2019.
- Al-Khatib SM, et al. 2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death. Circulation. 2018.
- Page RL, et al. 2015 ACC/AHA/HRS Guideline for the Management of Adult Patients With Supraventricular Tachycardia. Circulation. 2016.
- Brugada J, et al. 2019 ESC Guidelines for the management of patients with supraventricular tachycardia. Eur Heart J. 2020.
- Appelboam A, et al. Postural modification to the standard Valsalva manoeuvre for emergency treatment of SVT (REVERT): a randomised controlled trial. Lancet. 2015.
- Link MS, et al. Part 7: Adult Advanced Cardiovascular Life Support. 2015 AHA Guidelines Update. Circulation. 2015.
| Version | Date | Changes |
|---|---|---|
| 1.0 | 2025-01-15 | Initial comprehensive version with 14-section template |